[{"symbol": "CHNA", "assetClass": "Equity", "aum": 9965813.040000001, "avgVolume": 534, "cusip": "26922A370", "description": "The Advisor attempts to invest all, or substantially all, of its assets in the component securities and depositary receipts that make up the index. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries.", "domicile": "US", "etfCompany": null, "expenseRatio": 0.79, "inceptionDate": "2018-08-15", "isin": "US26922A3703", "name": "Loncar China BioPharma ETF", "nav": 9.77, "navCurrency": "USD", "sectorsList": [{"industry": "Basic Materials", "exposure": 0}, {"industry": "Communication Services", "exposure": 0}, {"industry": "Consumer Cyclical", "exposure": 0}, {"industry": "Consumer Defensive", "exposure": 0}, {"industry": "Energy", "exposure": 0}, {"industry": "Financial Services", "exposure": 0}, {"industry": "Healthcare", "exposure": 100}, {"industry": "Industrials", "exposure": 0}, {"industry": "Real Estate", "exposure": 0}, {"industry": "Technology", "exposure": 0}, {"industry": "Utilities", "exposure": 0}], "website": "", "holdingsCount": 57}]